Cue Biopharma Inc (CUE)
1.63
+0.04
(+2.52%)
USD |
NASDAQ |
May 31, 16:00
1.62
-0.01
(-0.61%)
After-Hours: 20:00
Cue Biopharma Price: 1.63 for May 31, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 31, 2024 | 1.57 | 1.64 | 1.55 | 1.63 | 186545.0 |
May 30, 2024 | 1.60 | 1.659 | 1.55 | 1.59 | 150034.0 |
May 29, 2024 | 1.59 | 1.67 | 1.57 | 1.58 | 182960.0 |
May 28, 2024 | 1.64 | 1.79 | 1.57 | 1.62 | 229372.0 |
May 24, 2024 | 1.75 | 1.75 | 1.62 | 1.625 | 202834.0 |
May 23, 2024 | 1.91 | 1.935 | 1.70 | 1.74 | 160345.0 |
May 22, 2024 | 1.90 | 1.92 | 1.81 | 1.91 | 200183.0 |
May 21, 2024 | 1.84 | 1.94 | 1.74 | 1.885 | 185328.0 |
May 20, 2024 | 1.74 | 1.94 | 1.71 | 1.87 | 313865.0 |
May 17, 2024 | 1.74 | 1.77 | 1.66 | 1.71 | 117895.0 |
May 16, 2024 | 1.63 | 1.86 | 1.63 | 1.74 | 278368.0 |
May 15, 2024 | 1.65 | 1.665 | 1.52 | 1.64 | 263507.0 |
May 14, 2024 | 1.70 | 1.74 | 1.54 | 1.55 | 614521.0 |
May 13, 2024 | 1.74 | 1.83 | 1.65 | 1.65 | 98120.00 |
May 10, 2024 | 1.93 | 1.990 | 1.62 | 1.74 | 449013.0 |
May 09, 2024 | 1.90 | 1.979 | 1.84 | 1.915 | 171339.0 |
May 08, 2024 | 2.12 | 2.13 | 1.84 | 1.91 | 261073.0 |
May 07, 2024 | 2.09 | 2.20 | 2.07 | 2.18 | 240273.0 |
May 06, 2024 | 2.07 | 2.26 | 2.05 | 2.08 | 319295.0 |
May 03, 2024 | 1.90 | 2.19 | 1.87 | 2.13 | 663094.0 |
May 02, 2024 | 1.91 | 1.936 | 1.76 | 1.88 | 226091.0 |
May 01, 2024 | 1.92 | 1.986 | 1.60 | 1.905 | 622040.0 |
Apr 30, 2024 | 1.40 | 1.98 | 1.37 | 1.90 | 1.261M |
Apr 29, 2024 | 1.39 | 1.48 | 1.38 | 1.42 | 155923.0 |
Apr 26, 2024 | 1.40 | 1.44 | 1.315 | 1.365 | 264389.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.365
Minimum
Apr 26 2024
30.73
Maximum
Jun 02 2020
8.924
Average
7.74
Median
Jun 26 2019
Price Benchmarks
NovaBay Pharmaceuticals Inc | 3.44 |
Palatin Technologies Inc | 1.80 |
iBio Inc | 2.38 |
Theriva Biologics Inc | 0.2501 |
Oragenics Inc | 2.02 |
Price Related Metrics
PS Ratio | 10.90 |
Price to Book Value | 2.640 |
Earnings Yield | -65.64% |
Market Cap | 79.29M |